Evidence map›Paper›PMID 26254329›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2015

Alagebrium inhibits neointimal hyperplasia and restores distributions of wall shear stress by reducing downstream vascular resistance in obese and diabetic rats.

Hongfeng Wang, Dorothee Weihrauch, Judy R Kersten, Jeffrey M Toth, Anthony G Passerini, Anita Rajamani, Sonja Schrepfer, John F LaDisa

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Alagebrium and Complications of Diabetes Mellitus.The Eurasian journal of medicine · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Hongfeng WangDepartment of Biomedical Engineering, Marquette University, Milwaukee, Wisconsin;
Dorothee WeihrauchDepartment of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin;
Judy R KerstenDepartment of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin;
Jeffrey M TothDepartment of Biomedical Engineering, Marquette University, Milwaukee, Wisconsin; Department of Orthopaedic Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin;
Anthony G PasseriniDepartment of Biomedical Engineering, University of California Davis, Davis, California;
Anita RajamaniDepartment of Biomedical Engineering, University of California Davis, Davis, California;
Sonja SchrepferTransplant and Stem Cell Immunobiology Laboratory, University Heart Center and Cardiovascular Research Center, University of Hamburg, Hamburg, Germany; Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California;
John F LaDisaDepartment of Biomedical Engineering, Marquette University, Milwaukee, Wisconsin; Department of Medicine, Division of Cardiovascular Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Biotechnology and Bioengineering Center, Medical College of Wisconsin, Milwaukee, Wisconsin john.ladisa@marquette.edu.
Medical College of Wisconsin · USMarquette University · USUniversity of California, Davis · USUniversität Hamburg · DE

Funding

Vascular Mimetics to Study Inflammation and AtherosclerosisR01HL082689 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI PASSERINI, ANTHONY G., SIMON, SCOTT IRWIN · 2008 to 2016
$3.2M
NHLBI NIH HHS R01 HL082689
6 · The paper itself

Abstract

Mechanisms of restenosis in type 2 diabetes mellitus (T2DM) are incompletely elucidated, but advanced glycation end-product (AGE)-induced vascular remodeling likely contributes. We tested the hypothesis that AGE-related collagen cross-linking (ARCC) leads to increased downstream vascular resistance and altered in-stent hemodynamics, thereby promoting neointimal hyperplasia (NH) in T2DM. We proposed that decreasing ARCC with ALT-711 (Alagebrium) would mitigate this response. Abdominal aortic stents were implanted in Zucker lean (ZL), obese (ZO), and diabetic (ZD) rats. Blood flow, vessel diameter, and wall shear stress (WSS) were calculated after 21 days, and NH was quantified. Arterial segments (aorta, carotid, iliac, femoral, and arterioles) were harvested to detect ARCC and protein expression, including transforming growth factor-β (TGF-β) and receptor for AGEs (RAGE). Downstream resistance was elevated (60%), whereas flow and WSS were significantly decreased (44% and 56%) in ZD vs. ZL rats. NH was increased in ZO but not ZD rats. ALT-711 reduced ARCC and resistance (46%) in ZD rats while decreasing NH and producing similar in-stent WSS across groups. No consistent differences in RAGE or TGF-β expression were observed in arterial segments. ALT-711 modified lectin-type oxidized LDL receptor 1 but not RAGE expression by cells on decellularized matrices. In conclusion, ALT-711 decreased ARCC, increased in-stent flow rate, and reduced NH in ZO and ZD rats through RAGE-independent pathways. The study supports an important role for AGE-induced remodeling within and downstream of stent implantation to promote enhanced NH in T2DM.

Indexed as

StentsStress, MechanicalAnimalsAorta, AbdominalCollagenDiabetes MellitusGlycation End Products, AdvancedGraft Occlusion, VascularMaleNeointimaObesityRatsRats, ZuckerReceptor for Advanced Glycation End ProductsShear StrengthThiazolesAger protein, ratalagebriumCollagenGlycation End Products, AdvancedReceptor for Advanced Glycation End ProductsThiazolesTransforming Growth Factor betacoronary artery diseasehemodynamicshyperglycemiainterventional cardiologyrestenosis

Identifiers

PMID26254329
PMCPMC4865061
OpenAlexW2112399028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.